Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · Real-Time Price · USD
90.14
+1.21 (1.36%)
At close: Dec 20, 2024, 4:00 PM
90.00
-0.14 (-0.16%)
After-hours: Dec 20, 2024, 4:55 PM EST

Blueprint Medicines Stock Forecast

Stock Price Forecast

The 19 analysts with 12-month price forecasts for Blueprint Medicines stock have an average target of 120.79, with a low estimate of 76 and a high estimate of 168. The average target predicts an increase of 34.00% from the current stock price of 90.14.

Analyst Consensus: Buy
Target Low Average Median High
Price $76 $120.79 $125 $168
Change -15.69% +34.00% +38.67% +86.38%

Analyst Ratings

The average analyst rating for BPMC stock from 20 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jul '24Aug '24Sep '24Oct '24Nov '24Dec '24
Strong Buy 566667
Buy 566677
Hold 444555
Sell 000000
Strong Sell 111111
Total 151717181920

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Guggenheim
Guggenheim
Strong Buy
Reiterates
n/a
Strong Buy Reiterates n/a n/a Dec 11, 2024
JMP Securities
JMP Securities
Buy
Reiterates
$125
Buy Reiterates $125 +38.67% Dec 9, 2024
JMP Securities
JMP Securities
Buy
Reiterates
$125
Buy Reiterates $125 +38.67% Nov 18, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$135
Strong Buy Reiterates $135 +49.77% Nov 15, 2024
Needham
Needham
Strong Buy
Reiterates
$135
Strong Buy Reiterates $135 +49.77% Nov 15, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
518.93M
from 249.38M
Increased by 108.09%
Revenue Next Year
723.08M
from 518.93M
Increased by 39.34%
EPS This Year
-1.00
from -8.37
EPS Next Year
-0.97
from -1.00
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
66.51M793.74M180.08M204.04M249.38M518.93M723.08M959.83M
Revenue Growth
49.39%1,093.37%-77.31%13.30%22.22%108.09%39.34%32.74%
EPS
-7.275.59-11.01-9.35-8.37-1.00-0.971.74
EPS Growth
--------
Forward PE
-------51.93
No. Analysts -----222222
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026202720282029
High 548.8M 811.7M 1.2B
Avg 518.9M 723.1M 959.8M
Low 493.4M 560.7M 744.5M

Revenue Growth

Revenue Growth 202420252026202720282029
High
120.1%
56.4%
63.5%
Avg
108.1%
39.3%
32.7%
Low
97.8%
8.0%
3.0%

EPS Forecast

EPS 20242025202620272028
High -0.82 3.06 6.04
Avg -1.00 -0.97 1.74
Low -1.23 -2.78 -1.22

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.